Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03409380 · ClinicalTrials.gov registry record · NA

Supplementation Trial on Arginine With Metabolic Profiling

A NA study, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT03409380 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03409380, a NA study, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

This study will assess effects of an acute dose of the amino acid arginine on metabolism in healthy young men.

Interventions

  • DIETARY_SUPPLEMENT Arginine Drink
  • DIETARY_SUPPLEMENT Plain Drink

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2018-02-08
Est. Completion 2019-07-08
Phase NA

What the Registry Record Tells You About NCT03409380

The ClinicalTrials.gov registry entry for NCT03409380 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Arginine Drink is the first listed.

NCT03409380 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03409380 about?

NCT03409380 is a clinical study titled "Supplementation Trial on Arginine With Metabolic Profiling". This study will assess effects of an acute dose of the amino acid arginine on metabolism in healthy young men.

What is the current status of trial NCT03409380?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-02-08. Estimated completion is 2019-07-08.

What interventions are being tested in trial NCT03409380?

The interventions under investigation include: Arginine Drink (DIETARY_SUPPLEMENT), Plain Drink (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03409380?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.